Pharma News

Mirati Therapeutics has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2 trial with the initial goal to evaluate safety, tolerability and pharmacokinetics of the company's KRA

A Phase III clinical trial showed that women with hormone receptor-positive metastatic breast cancer had improved survival when using palbociclib in combination with standard treatment.

AstraZeneca’s three main therapy areas of Oncology, Cardiovascular, Renal & Metabolism and Respiratory. Nexium has lost compound patent protection in the majority of global markets. Vimovo is patent protected in most European markets until 2025.

The first-line treatment for this debilitating disease are progestin-based therapies such as oral contraceptives. These are aimed at managing the pain.

“We’ve now established that high-dose cisplatin chemotherapy – in combination with radiation – is the standard of care for human papillo...

Regulatory Partnership to develop cost effective regenerative medicine

What began as a trend across the pharmaceutical industry is now so firmly established it could be considered the norm;

“The Middle East and Africa market is evolving at a rapid pace, and opportunities are plentiful for regional and international pharma co...

“Recent technical advancements and new government regulations have led to the rapid development of new, cost effective testing for the e...

“Our new facility was built in response to increasing customer demand for our early-phase formulation development and clinical trial man...

Natural health medicine has the benefits in that it is one of the few medicines that have little or no side effects.

The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla’s latest first-line triple-combination antiretroviral (ARV) treatment for HIV. The new combination medicine, commonly referred to as TLD, is a combination of tenofovir (TDF

A joint scientific study report by commissioned by the Ministry of Heavy Industries & Public Enterprises and conducted by The Energy Resources Institute (TERI) and the Automotive Research Association of India (ARAI) has said that strong policies are n

Clinical trials are expected to grow at a compound annual growth rate of 14 percent from 2014 to 2019, to reach an estimated value of $1,848.5 million

120-crore to set up this new production line, which will boost the capacity to manufacture liquid vials, injectables, eye drops and tabl...

One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1 billion for the fiscal year 2012, marking a growth of 4.5 percent f

Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing its product line with acquisitions that took place in 2012. The company strengthened its product base by launching new products such as A

Researchers have found that some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions about reimbursing cancer drugs following European Medicines Agency (EMA) approval.

Swiss pharmaceutical firm Novartis has signed a $2.1bn deal to acquire all outstanding shares of US-based biopharmaceutical company Endocyte in order to bolster its position in radiopharmaceuticals.

A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD). Researchers at the Westmead Institute for Medical Rese